BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1 AND Prognosis
8 results:

  • 1. prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study.
    Kruger SF; Lohneis A; Abendroth A; Berger AW; Ettrich TJ; Waidmann O; Kapp M; Steiner B; Kumbrink J; Reischer A; Haas M; Westphalen CB; Zhang D; Miller-Phillips L; Burger PJ; Kobold S; Werner J; Subklewe M; von Bergwelt-Baildon M; Kunzmann V; Seufferlein T; Siveke JT; Sinn M; Heinemann V; Ormanns S; Boeck S
    ESMO Open; 2022 Feb; 7(1):100388. PubMed ID: 35121522
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for pancreatic cancer.
    Feng L; Wang Y; Qin J; Fu Y; Guo Z; Zhang J; He G; Jiang Z; Xu X; Zhou C; Gao Y
    Biomed Res Int; 2021; 2021():6673125. PubMed ID: 34595239
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ductal adenocarcinoma.
    Park E; Yoo JE; Hwang HK; Kang CM; Lee CK; Kim MH; Bang S; Park YN
    J Hepatobiliary Pancreat Sci; 2022 Feb; 29(2):250-261. PubMed ID: 34318617
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Blocking the road to de-differentiation: hnf1a/KDM6A complex safeguards epithelial integrity in pancreatic cancer.
    Bärthel S; Schneider G; Saur D
    EMBO J; 2020 May; 39(9):e104759. PubMed ID: 32236961
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. hnf1a inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1.
    Lu Y; Xu D; Peng J; Luo Z; Chen C; Chen Y; Chen H; Zheng M; Yin P; Wang Z
    EBioMedicine; 2019 Jun; 44():403-418. PubMed ID: 31103629
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Investigating the role of transcription factors of pancreas development in pancreatic cancer.
    Naqvi AAT; Hasan GM; Hassan MI
    Pancreatology; 2018 Mar; 18(2):184-190. PubMed ID: 29289465
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response.
    Muckenhuber A; Berger AK; Schlitter AM; Steiger K; Konukiewitz B; Trumpp A; Eils R; Werner J; Friess H; Esposito I; Klöppel G; Ceyhan GO; Jesinghaus M; Denkert C; Bahra M; Stenzinger A; Sprick MR; Jäger D; Springfeld C; Weichert W
    Clin Cancer Res; 2018 Jan; 24(2):351-359. PubMed ID: 29101303
    [No Abstract]    [Full Text] [Related]  

  • 8. hnf1a/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling.
    Yu Y; Liang S; Zhou Y; Li S; Li Y; Liao W
    J Cell Biochem; 2019 Mar; 120(3):2816-2827. PubMed ID: 28865121
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.